Report anticipates end to equipment purchase freezes
Most U.S. hospital radiology administrators expect restrictions against capital acquisitions to ease and plan to buy the diagnostic imaging equipment they most sorely need later this year, according to the latest report by healthcare market research firm IMV.
Most U.S. hospital radiology administrators expect restrictions against capital acquisitions to ease and plan to buy the diagnostic imaging equipment they most sorely need later this year, according to the latest report by healthcare market research firm IMV.
The Des Plaines, IL, firm surveyed 250 acute care hospitals. It found about 70% of radiology departments had partial or total capital equipment spending freezes in place because of the financial crisis. But it also found that radiology administrators in two of three hospitals plan to buy imaging equipment this year despite the recession. High-priority items include digital mammography, digital radiography, fluoroscopy, and multislice (64+) CT equipment. IMV found that many hospitals are scheduling the move toward PACS and that two of five current PACS users plan upgrades in the next two years.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
